Nuvation Bio (NYSE:NUVB) Given New $7.00 Price Target at HC Wainwright
Nuvation Bio (NYSE:NUVB – Free Report) had its price objective trimmed by HC Wainwright from $8.00 to $7.00 in a research report released on Monday morning, Benzinga reports. The firm currently has a buy rating on the stock. Several other brokerages have also commented on NUVB. Royal Bank of Canada reissued an outperform rating and […]
More Stories
Knight Therapeutics (OTCMKTS:KHTRF) Trading 5.2% Higher – Here’s Why
Knight Therapeutics Inc. (OTCMKTS:KHTRF – Get Free Report)’s stock price traded up 5.2% on Tuesday . The company traded as...
Analyzing SBA Communications (NASDAQ:SBAC) & TPG RE Finance Trust (NYSE:TRTX)
SBA Communications (NASDAQ:SBAC – Get Free Report) and TPG RE Finance Trust (NYSE:TRTX – Get Free Report) are both finance...
Halma (OTCMKTS:HLMAF) Stock Price Up 0.6% – Time to Buy?
Shares of Halma plc (OTCMKTS:HLMAF – Get Free Report) traded up 0.6% during mid-day trading on Tuesday . The company...
New Commerce Split Fund (TSE:YCM) Shares Down 3.6% – Here’s What Happened
New Commerce Split Fund (TSE:YCM – Get Free Report)’s stock price traded down 3.6% on Tuesday . The company traded...
Borders & Southern Petroleum (LON:BOR) Trading Down 6.3% – Should You Sell?
Borders & Southern Petroleum plc (LON:BOR – Get Free Report) dropped 6.3% during trading on Tuesday . The stock traded...
Evonik Industries (FRA:EVK) Shares Up 1.5% – Should You Buy?
Evonik Industries AG (FRA:EVK – Get Free Report) shot up 1.5% on Tuesday . The company traded as high as...